Vacc RedCx
Alternative Names: Vacc-RedCxLatest Information Update: 02 Feb 2023
At a glance
- Originator Immunor AS
- Class Bacterial vaccines; Peptide vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
- Available For Licensing Yes
Highest Development Phases
- Research Periodontitis
Most Recent Events
- 10 Jan 2023 Vacc RedCx is available for licensing as of 10 Jan 2023. https://immunor.com/projects/
- 10 Jan 2023 Early research in Periodontitis (Prevention) in Norway (unspecified route) before January 2023 (Immunor AS pipeline, January 2023)
- 10 Jan 2023 Early research in Periodontitis in Norway (unspecified route) before January 2023 (Immunor AS pipeline, January 2023)